Clinical Trials
6 trialsNCT00207090 2020-11-02
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer
R-Pharm
Phase 1 Completed
NCT00207129 2017-01-30
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies
R-Pharm
Phase 1 Completed
NCT00309049 2017-01-30
Ixabepilone Administered as an Enteric Coated Formulation.
R-Pharm
Phase 1/2 Completed
NCT00362830 2016-09-19
A Study of the Alternative Administration of Ixabepilone and Vinflunine
Bristol-Myers Squibb
Phase 1 Completed
NCT00422097 2016-03-10
A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer
R-Pharm
Phase 1 Completed
NCT00798252 2015-07-07
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Bristol-Myers Squibb
Phase 1 Completed